Re: Fwd: [QUAD-L] Cipro Warning

[greg]

Me too, I took it anyway. I'm alergic to Macrobid, so not many option that work for me. Greg > Well that's wonderful. Cipro and levaquin have always been my go-to > drugs. > > Larry WillisRetired and proud of it > > > Begin forwarded message: > > >> Resent-From: quad-list@eskimo.com >> From: greg <g...@eskimo.com> >> Date: February 9, 2017 at 10:58:35 PM EST >> To: <quad-list@eskimo.com> >> Subject: [QUAD-L] Cipro Warning >> >> >> Just got a UTI. I always used Cipro, but they have a new danger >> warning. So importent, its called a "Black Box" waning........ > > > FDA Says Risks May Outweigh Benefits for Antibiotics Levaquin, > Cipro Posted May 16th, 2016    by Michelle Llamas & filed under FDA > News & Recalls.   > Did you experience aortic complications after taking > fluoroquinolones? > > On May 12, 2016, the U.S. Food and Drug Administration announced it > is requiring a stronger black box warning for common, popular > antibiotics called fluoroquinolones that include Levaquin > (levofloxacin), Cipro (ciprofloxacin) and Avelox (moxifloxacin) — > medications taken by more than 26 million Americans each year. > > "The U.S. Food and Drug Administration is advising that the serious > side effects associated with fluoroquinolone antibacterial drugs > generally outweigh the benefits for patients with sinusitis, > bronchitis, and uncomplicated urinary tract infections who have > other treatment options," the FDA said in a Drug Safety > Communication. "For patients with these conditions, > fluoroquinolones should be reserved for those who do not have > alternative treatment options." > > The agency's action comes after its FDA Advisory Committee meeting > in November 2015. This is not the first warning for these drugs > released by the FDA. It previously added boxed warnings in 2008 for > tendon rupture and tendinitis and again in 2013 for permanent nerve > damage called peripheral neuropathy. > > The new boxed warning advises patients and doctors that these > antibiotics may cause potentially permanent damage to muscles, > tendons, joints, nerves and the central nervous system. In patients > with minor infections such as sinusitis and bronchitis, the risk > outweighs the benefits, the FDA panel found. In these cases, other > treatments are often available and the agency strongly discourages > doctors from prescribing them.